Indeed, CHEK2 down-regulation in fibroblasts paracrinaly induced the three major mesenchymal markers N-cadherin, Twist-1 and vimentin, and decreased two major epithelial markers E-cadherin and Epcam in breast cancer cells. This evidence concerns the gene EPCAM and breast cancer.